AB ANALITICA is a company specialized in the development and sale of diagnostic systems for professional use. AB ANALITICA carries out in-house development and production of reagent kits, automatic interpretation software and automation solutions mainly for molecular diagnostics applications, as well as systems for biobank management and biological samples traceability. The company has a track-record of successfully implementing and commercializing diagnostic methods that quantitatively and qualitatively detect disease-related genetic mutations, risk alleles for multifactorial diseases and cancer chromosomal rearrangements using reverse-line blot and Real-Time PCR. In DECIDER, AB ANALITICA is developing a diagnostic test for prediction of response to therapy. Read more on the AB Analitica Website.